AC MÉDICAL
ActiveSummary
The annual accounts of AC MÉDICAL for fiscal year 2024 show a net loss of 100% of total assets and of 86% of the equity at the start of that year. The 2024 annual accounts show equity of €3k and a net result of €-18k. Equity is shrinking by ~35.3% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2025. Its solvency ranks better than 13% of 19908 sector peers (fiscal year 2024). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2024
48
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability0▼-100
Solvency42▼-40
Growth32▼-46
Track record94
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
No publishable credit limit; credit only on tighter terms
Net loss of at least half of total assets or of the equity at the start of the financial year.
Liquidity short (current ratio 0.98 against 2.31 in 2023; short-term debt: 83.5% and cash: 58.1% of total assets), and 83.5% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
16.5%
Return on assets
-100%
Age of the figures
21 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 13% of 19908 sector peers (2024).
NBB · sector comparisonPosition among 19908 sector peers
Solvency
better than 13%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 19-09-2025, 50 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 3 filingsDeviation from the deadline
2025
not confirmed
2024
50 d late
2023
51 d late
2022
59 d late
← before the deadline
after the deadline →
Checked, nothing found (1)
Financials · fiscal year 2024, micro schema
Equity
€3k▼ 85.8%
2023 · €22k
2022: €10k
2023: €22k
2022 → 2024
Total assets
€18k▼ 51.3%
2023 · €38k
2022: €17k
2023: €38k
2022 → 2024
Net result
€-18k
2023 · €12k
2022: €8k
2023: €12k
2022 → 2024
Working capital
€-300
2023 · €22k
2022: €10k
2023: €22k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202220232024Trend
Equity€10k-€22k▲ 108%€3k▼ 85.8%
Operating result€11k-€16k▲ 48.4%€-18k
Net result€8k-€12k▲ 46.6%€-18k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2024: a loss of €18k after €16k in 2023, the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €18k
Fixed assets
€3k
Current assets
€15k
Equity and liabilities €18k
Equity
€3k ▼ 85.8%
Debt
€15k ▼ 6.0%
Debt's share of the balance-sheet total rises from 43.3% to 83.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
€-18k
Cash flow
€-18k
Current ratio
0.98▼
2023 · 2.31
Debt to equity
5.06▲
2023 · 0.76
ROE
-605.8%▼
2023 · 55.6%
ROA
-100.0%▼
2023 · 31.5%
Interest coverage
-239.99
Debt ≤ 1 year
€15k▼
2023 · €16k
Income taxes
€6▼
2023 · €4k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2024 against 2023 · 37 lines
Balance sheet
Code20232024
Assets
Total assets20/58€38k€18k▼
Fixed assets21/28-€3k
Tangible fixed assets22/27-€3k
Furniture and vehicles24-€1k
Other tangible fixed assets26-€2k
Current assets29/58€38k€15k▼
Amounts receivable within one year40/41€1k€830▼
Trade receivables40€1k€830▼
Cash at bank and in hand54/58€37k€11k▼
Deferred charges and accrued income490/1-€4k
Equity and liabilities
Total equity and liabilities10/49€38k€18k▼
Equity10/15€22k€3k▼
Contributions10/11€3k€3k=
Profit (loss) carried forward14€19k€50▼
Amounts payable17/49€16k€15k▼
Amounts payable within one year42/48€16k€15k▼
Trade debts44-€3k
Suppliers440/4-€3k
Taxes, remuneration and social security45€7k€6k▼
Taxes450/3€7k€6k▼
Other amounts payable47/48€10k€6k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€414
Other operating charges640/8€285€184▼
Gross operating margin9900€16k€-18k▼
Operating profit (loss)9901€16k€-18k▼
Financial income75/76B-€18
Recurring financial income75-€18
Financial charges65/66B-€75
Recurring financial charges65-€75
Profit (loss) for the period before taxes9903€16k€-18k▼
Income taxes67/77€4k€6▼
Profit (loss) for the period9904€12k€-18k▼
Profit (loss) for the period to be appropriated9905€12k€-18k▼
Appropriation of the result
Profit (loss) to be appropriated9906€19k€50▼
Profit (loss) brought forward from the previous period14P€7k€19k▲
Profit to be distributed694/7€800-
Return on contributions (dividend)694€800-
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
19-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 50 days late
2024
31-12
Financial
Weakest financial yearnet €-18k
Net result drops to €-18k, the lowest in the series.
20-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 51 days late
2023
31-12
Financial
Highest result since 2022net €12k ▲46.6%
Operating result €16k, net result €12k, both a record.
28-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 59 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 1 establishment unit since 2022
Ground area
161 m²
Building footprint
113 m²
Volume, LiDAR
1,310 m³
Parcel 21910E0183/00E013, Brussels · tallest building 17.0 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
AC MÉDICAL
since 20222.333.725.968
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21910E0183/00E013 | Brussels | 161 m² | 1 · 113 m² | 16.9 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. ELFRI VAN ROY
BE 1029.174.156
Leuven · Eq €3,053
DR. TINE BERGMANS
BE 1014.946.830
Tielt-Winge · Eq €3,077
Docteur Nicolas DURIEUX
BE 0787.684.441
Chaudfontaine · Eq €3,020
VARIMED
BE 0779.872.080
Morlanwelz · Eq €3,003
Praktijkhuis Baarle
BE 0689.587.549
Baarle-Hertog · Eq €3,001
Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 1,036 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded11-07-2022
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:0472426807